Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine, ketamine, or fentanyl added to PCA after abdominal hysterectomy
IRCT20251202068195N1Phase 3Recruiting
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine, ketamine and fentanyl in postoperative pain (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Pain intensity, Incidence of complications and 1 more. Started Jan 2026; status: recruiting.
02
Drugs
dexmedetomidineketaminefentanyl
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20251202068195N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251202068195N1.